Luke Henry, PhD

Luke Henry, PhD has extensive work experience in various roles and companies. Luke currently serves as the Chief Business Officer at Quell Therapeutics, a position they have held since June 2021. Prior to this, they were the VP of Operations & Corporate Development at Quell Therapeutics from July 2019 to June 2021.

Before joining Quell Therapeutics, Luke held key positions at Neon Therapeutics. Luke worked as the Senior Director of Business Development & Strategy from July 2017 to June 2019 and as the Director of Business Development & Strategy from June 2016 to June 2017.

Luke also has a background in consulting, having worked at the Boston Consulting Group (BCG) for several years. Luke held the title of Principal from April 2015 to June 2016, Project Leader from July 2013 to March 2015, Consultant from July 2011 to June 2013, and Junior Consultant from January 2010 to June 2011.

Additionally, Luke gained early experience in finance at Lazard, where they worked as a Summer Analyst in 2004. Luke also had a Summer Internship at Ernst & Young in 2003.

Overall, Luke Henry, PhD has a diverse background in business development, strategy, and consulting, with a demonstrated track record of success in the biotechnology industry.

Luke Henry, PhD completed their education with a Bachelor of Arts (BA) and Master of Sciences (M.Sci.) degree in Natural Sciences from the University of Cambridge. Luke pursued further studies at The Institute of Cancer Research, earning a PhD in Molecular and Cellular Oncology.